Spectrum Equity VII, L.P. sold GDRX

September 4, 2025 · Form 4 insider transaction

Spectrum Equity VII, L.P. sold 5,983,984 shares of GoodRx Holdings, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as j and disclosed on an SEC Form 4, filed 4 days after the transaction.

Direction
Disposed (sell-side)
Shares
5,983,984
Price
$0.00
Total value
N/A
Role10% owner
SecurityClass A Common Stock
Transaction codeJ: J
Transaction dateSeptember 4, 2025
Filing dateSeptember 8, 2025
Shares owned after0
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

Spectrum Equity VII, L.P. made a pro rata distribution of 5,983,984 shares of Class A Shares to its general partner and limited partners for no consideration on September 4, 2025.; The general partner of Spectrum Equity VII, L.P. ("SE VII") is Spectrum Equity Associates VII, L.P. ("Spectrum Equity Associates"). The general partner of each of Spectrum VII Investment Managers' Fund, L.P. ("Spectrum VII Investment Managers' Fund"), Spectrum VII Co-Investment Fund L.P. ("Spectrum VII Co-Investment Fund"), and Spectrum Equity Associates is SEA VII Management, LLC ("Management LLC"). Brion B. Applegate, Christopher T. Mitchell, Victor E. Parker, Jr., Benjamin C. Spero, Ronan Cunningham, Stephen M. LeSieur, Brian Regan and Michael W. Farrell may be deemed to share voting and dispositive power over the securities held by SE VII, Spectrum VII Investment Managers' Fund and Spectrum VII Co-Investment Fund. Each of these individuals disclaims beneficial ownership of such securities, except to the extent of their pecuniary interest, if any.

View the original Form 4 on SEC EDGAR